Marsha Rosengarten
Overview
Explore the profile of Marsha Rosengarten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosengarten M
Med Humanit
. 2022 May;
49(1):64-69.
PMID: 35636932
This article revisits long-standing critiques of the role of metaphor in immunological discourse. Drawing on Alfred North Whitehead's speculative philosophy of organism, I focus on the use of metaphor to...
2.
3.
Savransky M, Rosengarten M
Med Humanit
. 2016 May;
42(3):166-72.
PMID: 27222529
Expanding on the recent call for a 'critical medical humanities' to intervene in questions of the ontology of health, this article develops a what we call a 'speculative' orientation to...
4.
Holt M, Lea T, Schmidt H, Murphy D, Rosengarten M, Crawford D, et al.
AIDS Behav
. 2016 Jan;
20(7):1564-71.
PMID: 26803613
We surveyed Australian gay and bisexual men, assessing belief in HIV treatment as prevention (TasP) and support for early treatment. We identified the characteristics of participants who believed in TasP...
5.
Murphy D, Lea T, de Wit J, Ellard J, Kippax S, Rosengarten M, et al.
Sex Transm Infect
. 2014 Nov;
91(4):266-8.
PMID: 25416839
Objective: We assessed interest in using rectal microbicides to prevent HIV transmission among gay men in Australia. Methods: A national online survey was conducted in 2013. Interest in using rectal...
6.
Holt M, Lea T, Murphy D, Ellard J, Rosengarten M, Kippax S, et al.
PLoS One
. 2014 Nov;
9(11):e112349.
PMID: 25386943
Objective: Assess the acceptability of HIV treatment as prevention and early antiretroviral treatment among gay and bisexual men in Australia and any changes in attitudes over time. Methods: National, online,...
7.
Holt M, Lea T, Murphy D, Ellard J, Rosengarten M, Kippax S, et al.
J Acquir Immune Defic Syndr
. 2014 Aug;
67(2):222-6.
PMID: 25078535
We surveyed willingness to use pre-exposure prophylaxis (PrEP) and the likelihood of decreased condom use among Australian gay and bisexual men in 2011 and 2013 (n = 2384). Willingness to...
8.
Holt M, Murphy D, Callander D, Ellard J, Rosengarten M, Kippax S, et al.
AIDS Behav
. 2012 Sep;
17(6):2156-61.
PMID: 23001412
We assessed attitudes to medicines, HIV treatments and antiretroviral-based prevention in a national, online survey of 1,041 Australian gay men (88.3% HIV-negative and 11.7% HIV-positive). Multivariate analysis of variance was...
9.
Holt M, Murphy D, Callander D, Ellard J, Rosengarten M, Kippax S, et al.
Sex Transm Infect
. 2012 Feb;
88(4):258-63.
PMID: 22290327
Objectives: To investigate willingness to use HIV pre-exposure prophylaxis (PrEP) and the likelihood of decreased condom use among Australian gay and bisexual men. Methods: A national, online cross-sectional survey was...
10.
Rosengarten M, Michael M
Soc Sci Med
. 2009 Aug;
69(7):1049-55.
PMID: 19695756
This paper is about expectations of oral PrEP, 'a pill a day' HIV pre-exposure prophylaxis that could be the first systemic form of HIV prevention for sexual or needle stick...